Cargando…

Post-COVID 19 neurological syndrome: Are we facing a neuropsychiatric phenotype?

Detalles Bibliográficos
Autores principales:	Rubiano-Buitrago, José David, Rahiran-Ramírez, Angie Faizuly, Peña-Vargas, Diana Marcela, Paez-Rincon, Leidy Angelica, Lozada-Martinez, Ivan David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783075/ https://www.ncbi.nlm.nih.gov/pubmed/35077946 http://dx.doi.org/10.1016/j.jocn.2022.01.010

Ejemplares similares

Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms
por: Troyer, Emily A., et al.
Publicado: (2020)

Neurosteroid Actions in Memory and Neurologic/Neuropsychiatric Disorders
por: Ratner, Marcia H., et al.
Publicado: (2019)

Editorial: Neurological Soft Signs in Neuropsychiatric Conditions
por: Toro, Pablo, et al.
Publicado: (2019)

Neurological, neuropsychiatric and neurodevelopmental complications of COVID-19
por: Pantelis, Christos, et al.
Publicado: (2020)

The Many Faces of Stress: Implications for Neuropsychiatric Disorders
por: Musazzi, Laura, et al.
Publicado: (2016)

Neurological and neuropsychiatric disorders associated with COVID-19. Part II: neuropsychiatric disorders and final consideration
por: Giacalone, Martina, et al.
Publicado: (2021)

Neuropsychiatric Symptoms in Parkinson’s Disease: Beyond Complications
por: Kehagia, Angie A.
Publicado: (2016)

Reserpine in the Treatment of Neuropsychiatric, Neurological, and Related Clinical Problems
por: Fierman, Louis B.
Publicado: (1955)

Neurological and Neuropsychiatric Manifestations of Antiphospholipid-Antibody Syndrome (APS)
por: Asif, Saba, et al.
Publicado: (2022)

Neurological and neuropsychiatric comorbidities occurring in fatty liver diseases
por: Balmus, I. M., et al.
Publicado: (2023)

Neurological and neuropsychiatric manifestations in hospitalised patients with COVID-19
por: Lekpeh, Gondah, et al.
Publicado: (2023)

Neurological and neuropsychiatric disorders associated with COVID-19. Part I: overview and neurological disorders
por: Giacalone, Martina, et al.
Publicado: (2021)

Editorial: Role of Neuroinflammation in the Neuropsychiatric and Neurological Aspects of COVID-19
por: Tremblay, Marie-Eve, et al.
Publicado: (2022)

The Olfactory System as Marker of Neurodegeneration in Aging, Neurological and Neuropsychiatric Disorders
por: Bhatia-Dey, Naina, et al.
Publicado: (2021)

The role of Gadd45b in neurologic and neuropsychiatric disorders: An overview
por: Shen, Xiao-yue, et al.
Publicado: (2022)

Benefits of the Neurogenic Potential of Melatonin for Treating Neurological and Neuropsychiatric Disorders
por: Potes, Yaiza, et al.
Publicado: (2023)

Alternative patterns of deep brain stimulation in neurologic and neuropsychiatric disorders
por: Najera, Ricardo A., et al.
Publicado: (2023)

Towards an Outpatient Model of Care for Motor Functional Neurological Disorders: A Neuropsychiatric Perspective
por: Saxena, Aneeta, et al.
Publicado: (2020)

A step-by-step guide to creating an academic surgery interest group: Review article
por: Domínguez-Alvarado, Gonzalo, et al.
Publicado: (2021)

Post-COVID 19 neurological syndrome: Implications for sequelae’s treatment
por: Camargo-Martínez, William, et al.
Publicado: (2021)

Letter to the Editor on “Why is salt-sensitivity of blood pressure, a known cardiovascular risk factor, not treated?”
por: Diaz-Novoa, Leidy Johana, et al.
Publicado: (2021)

The (Poly)Pharmacology of Cannabidiol in Neurological and Neuropsychiatric Disorders: Molecular Mechanisms and Targets
por: Vitale, Rosa Maria, et al.
Publicado: (2021)

Editorial of Special Issue ‘Dissecting Neurological and Neuropsychiatric Diseases: Neurodegeneration and Neuroprotection’
por: Tanaka, Masaru, et al.
Publicado: (2022)

Biomedical Perspectives of Acute and Chronic Neurological and Neuropsychiatric Sequelae of COVID-19
por: Stefano, George B., et al.
Publicado: (2022)

nNOS and Neurological, Neuropsychiatric Disorders: A 20-Year Story
por: Zhu, Li-Juan, et al.
Publicado: (2023)

Nature and nurture in neuropsychiatric genetics: where do we stand?
por: Dick, Danielle M., et al.
Publicado: (2010)

The Significance of the Default Mode Network (DMN) in Neurological and Neuropsychiatric Disorders: A Review
por: Mohan, Akansha, et al.
Publicado: (2016)

Neuropsychiatric and neurological problems among Vitamin B12 deficient young vegetarians
por: Kapoor, Aneel, et al.
Publicado: (2017)

Letter to the Editor: “What Are the Long-Term Neurological and Neuropsychiatric Consequences of COVID-19?”
por: Pan, Yuehai, et al.
Publicado: (2020)

Multipronged Attack of Stem Cell Therapy in Treating the Neurological and Neuropsychiatric Symptoms of Epilepsy
por: Sadanandan, Nadia, et al.
Publicado: (2021)

Neuropsychiatric Disorders and COVID-19: What We Know So Far
por: Majolo, Fernanda, et al.
Publicado: (2021)

Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study
por: Varatharaj, Aravinthan, et al.
Publicado: (2020)

Neurological Face of Familial Mediterranean Fever
por: Bektaş, Polat Cengiz, et al.
Publicado: (2022)

The merits and problems of Neuropsychiatric Inventory as an assessment tool in people with dementia and other neurological disorders
por: Lai, Claudia KY
Publicado: (2014)

Gut microbiome in neuropsychiatric disorders
por: MEJÍA-GRANADOS, Diana Marcela, et al.
Publicado: (2022)

Neuropsychiatric Consequences of COVID-19: What Do We Know So Far?
por: Machado, Sergio, et al.
Publicado: (2022)

Potential Interactions between the Autonomic Nervous System and Higher Level Functions in Neurological and Neuropsychiatric Conditions
por: Bassi, Andrea, et al.
Publicado: (2015)

nNOS-mediated protein-protein interactions: promising targets for treating neurological and neuropsychiatric disorders
por: Gu, Yuanyuan, et al.
Publicado: (2021)

Editorial: Non-invasive brain stimulation techniques in neurological and neuropsychiatric disorders: Physiological and molecular evidence
por: Cambiaghi, Marco, et al.
Publicado: (2023)

Cation-Chloride Cotransporters KCC2 and NKCC1 as Therapeutic Targets in Neurological and Neuropsychiatric Disorders
por: Lam, Patricia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kvksgd74gs2fdpdv0vr9u1d7ql